PARP1-IN-15
PARP1-IN-15 (Compound 6) is a PARP1 inhibitor. PARP1-IN-15 inhibits tankyrase (TNKS) and facilitates DNA double-strand breaks damage. PARP1-IN-15 induces tumor cell apoptosis. PARP1-IN-15 has anti-cancer activity in triple-negative breast cancer (TNBC) cells and TNBC patient-derived organoids. PARP1-IN-15 can be used for research of TNBC with or without BRCA1 mutations[1].
Product Specifications
UNSPSC
12352005
Target
Apoptosis; PARP
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/parp1-in-15.html
Solubility
10 mM in DMSO
Smiles
O=C1NC(/C=C/C2=CC=C(O)C=C2)=NC3=CC=CC=C31
Molecular Formula
C16H12N2O2
Molecular Weight
264.28
References & Citations
[1]Gong R, et al. Identification and evaluation of a novel PARP1 inhibitor for the treatment of triple-negative breast cancer. Chem Biol Interact. 2023 Sep 1;382:110567.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7187450 Inquire
Rabbit anti-Caenorhabditis elegans F59B10.6 Polyclonal Antibody
Sign In for Pricing
View Details 
GTR15150660 1 Vial
Lentiviral human MFAP4 shRNA (UAS) - Lentiviral human MFAP4 shRNA (UAS, RFP) (100)
Sign In for Pricing
View Details E6456 96 Tests
Leucine-rich repeat serine/threonine-protein Kinase 1 (LRRK1) Human ELISA Kit
Sign In for Pricing
View Details 